State Of Wisconsin Investment Board Igm Biosciences, Inc. Transaction History

State Of Wisconsin Investment Board

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$3.94 - $8.79 $70,415 - $157,094	17,872 Added 152.39%	29,600 $245,000
Q3 2023 Nov 14, 2023	BUY	$6.66 - $10.64 $78,108 - $124,785	11,728 New	11,728 $97,000
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $144,762 - $253,569	9,388 New	9,388 $213,000
Q2 2022 Aug 15, 2022	SELL	$13.27 - $25.5 $581,226 - $1.12 Million	-43,800 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$13.42 - $29.73 $452,254 - $1 Million	33,700 Added 333.66%	43,800 $1.17 Million
Q2 2021 Aug 12, 2021	SELL	$57.98 - $96.6 $231,920 - $386,400	-4,000 Reduced 28.37%	10,100 $840,000
Q1 2021 May 17, 2021	BUY	$71.56 - $121.23 $293,396 - $497,043	4,100 Added 41.0%	14,100 $1.08 Million
Q4 2020 Feb 03, 2021	SELL	$47.41 - $115.03 $61,632 - $149,539	-1,300 Reduced 11.5%	10,000 $883,000
Q2 2020 Aug 12, 2020	BUY	$51.3 - $75.21 $184,680 - $270,756	3,600 Added 46.75%	11,300 $825,000
Q1 2020 May 06, 2020	BUY	$31.51 - $73.75 $242,627 - $567,875	7,700 New	7,700 $432,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.